Clinical Trials · NCT04974723

Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women

Phase
N/A
Recruitment status
Completed
Sponsor
Radius Health, Inc.
Enrollment
22,054
Start date
Jul 2021
Locations
1 site, United States
Primary endpoint
Number of Participants With a Nonvertebral Fracture
View Teriparatide compound reference